Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?

There are challenges when conducting SCI clinical trials that span broadly across medical, social, political, and economic considerations. Thus, we should employ an interdisciplinary approach when addressing these challenges in order to facilitate the evaluation of novel treatments for SCI.